AJMC - The American Journal of Managed Care

In the most recent update to the National Comprehensive Cancer Network® (NCCN®) guidelines for treating patients who have #multiplemyeloma, several important adjustments have been made: - Adjustments to primary and maintenance therapy for both transplant-eligible and transplant-ineligible patients - 5 new regimens added for anti-CD-38 refractory disease, including 2 Category 1 recommendations - Expanded section on CAR T-cell therapy with updated guidance - Revisions to diagnostic workup and imaging principles to improve patient care Learn more here: https://bit.ly/4fJJXRv

On this episode of #ManagedCareCast, we're talking with Josie Cooper, BA, executive director of the Alliance for Patient Access. Her study, "Utilization Management and Physician Burnout," involved a survey that assessed physician experiences with utilization management and #burnout, investigating a potential link between the 2. Listen here: https://bit.ly/3Zc5zPB

Episode 5 is now available! https://bit.ly/3YWxy5K Experts explore groundbreaking advances in menopause treatment, highlighting neurokinin-targeted therapies like fezolinetant and elinzanetant in this insightful episode. Learn how these innovations offer nonhormonal options for managing vasomotor symptoms, mood disturbances, and sleep disorders. Catch the latest on cutting-edge treatments! #AJMC #menopausemanagement #patientoutcomes

Diabetes is a leading cause of preventable blindness in the US, with diabetic retinopathy (DR) being the top cause in working-age adults. With November being Diabetic Eye Disease Awareness Month, here is a look at ways to reduce the risk of diabetic eye diseases, the burdens of a prognosis, and the latest ways technology is helping. 🔍 Continuous Glucose Monitoring (CGM) for Prevention: CGM can help reduce the risk of DR in patients with type 1 diabetes. 🌍 Equity in Care: Limited English proficiency can lead to later-stage DR diagnoses, highlighting the need for better access to care and screenings. 📡 Teleretinal Screening: A reliable tool for early DR detection, especially in areas with limited access to specialists. 💉 Treatment Adherence: Regular follow-ups and treatments are crucial but can be difficult for patients with long commutes or busy work schedules. 💊 GLP-1s and DR: The link between GLP-1 medications and DR remains debated, with some studies showing no worsening of retinopathy. Learn more here: https://bit.ly/3V9VSQg

This #Thanksgiving, take a moment to reflect on those facing #foodinsecurity. Food insecurity affects millions of Americans, contributing to chronic diseases, mental health issues, and #obesity. Despite existing support programs, many still lack access to nutritious food, especially in low-income communities where geography, income, and race worsen the problem. Learn more here: https://bit.ly/4i55uG3

🦃🍂 Happy Thanksgiving from AJMC! 🍂🦃 As we reflect on the year, we are incredibly grateful for the trust, support, and partnerships that have made our journey so meaningful. This Thanksgiving, we want to extend our heartfelt thanks to our clients, partners, and team members. Wishing you a joyful holiday filled with gratitude and togetherness. Thank you for being part of the AJMC family! 🍁 #HappyThanksgiving #Grateful #AJMC #Thankful

In this AJMC - The American Journal of Managed Care interview, Milind Desai, MD, MBA, Cleveland Clinic, reported on the drug’s safety profile and efficacy at this year’s American Heart Association (AHA) Scientific Sessions. Desai discussed in more detail the process of implementing the REMS program, which their findings suggest was a valuable tool in assessing the benefits of mavacamten and its ability to improve patients’ functional lung capacity and other associated disease symptoms. Watch now! #AJMC #AHA2024 #ClevelandClinic #REMSProgram

Dive into The Evidence Based Oncology® November issue for a must-read feature on the management of germline mutations in hereditary breast cancer. Don’t miss out—read now! https://bit.ly/413uvv1

You're Invited: Elevating Value in Cancer Care Join us on December 12, 2024, for an evening dedicated to advancing value-based cancer care. Location: The Westin Seattle, Seattle, WA Time: 5:00–9:00 PM PST Meet us at the Westin Seattle for this FREE event where you’ll connect with leaders in the industry and collaborate to drive innovation and improve patient outcomes. Discussion Topics: - Precision Medicine in NSCLC - Pharmacy Decision-Making in Value-Based Care - Best Practices in Skin Cancer Treatment Don’t miss this opportunity to make an impact—right in Seattle’s iconic downtown, where innovation is always reaching new heights. Register now! https://lnkd.in/e3QcT96t

Delayed intervention for #HidradenitisSuppurativa increases the risk of complications and decreases the effectiveness of available therapies, making symptoms harder to manage over time. Listen to the Managed Care Cast® to learn more about breaking the cycle of #HS https://bit.ly/3AHZZw5